SCHEDULE: Fairfax-Led Consortium Bids $10.25/Share for Kennedy-Wilson

A consortium led by Fairfax Financial Holdings Limited and William J. McMorrow has proposed to acquire all outstanding shares of Kennedy-Wilson Holdings, Inc. not already owned for $10.25 per share in cash.

Summary

• Fairfax Financial Holdings Limited and its affiliates, along with William J. McMorrow's Kona Management Holdco, LLC, have formed a consortium to acquire Kennedy-Wilson Holdings, Inc.
• The consortium collectively beneficially owns approximately 31% of Kennedy-Wilson's outstanding shares on an as-converted basis.
• The proposal is to acquire all remaining outstanding shares for $10.25 per share in cash.
• Fairfax and its affiliates currently beneficially own 30,950,036 shares, representing 19.9% of the class, due to a warrant exercise limitation. Without this restriction, they would own 38,703,549 shares (23.7%).
• The consortium is only interested in acquiring shares they do not already own and are not interested in selling their existing stake.
• The proposal anticipates the formation of a special committee of independent directors by Kennedy-Wilson's Board to evaluate the offer.
• The Joint Bidding Agreement outlines exclusive cooperation, cost-sharing (Fairfax pays 100% of Consortium Advisors and Management Holdco's legal advisors), and unanimous decision-making for key transaction terms between Management Holdco and Hamblin Watsa Investment Counsel Ltd. (HWIC).
• Existing shares held by Fairfax and Management Holdco will be rolled over into Bidco Common Units, aiming for tax-free, tax-deferred, or non-recognition treatment.

Sentiment

Score: 7

Explanation: The filing presents a clear, albeit non-binding, acquisition proposal at a specific cash price, which typically generates positive sentiment for target shareholders. The strong commitment from a reputable investor like Fairfax and the consortium's intent to not sell their existing stake add credibility. However, the non-binding nature and the right to withdraw introduce a degree of uncertainty, preventing a higher score.

Positives

• A concrete offer of $10.25 per share in cash provides a clear valuation for non-consortium shareholders.
• The consortium's stated intent to acquire all remaining shares, rather than sell their own, indicates a strong commitment to the transaction.
• Fairfax Financial Holdings Limited's commitment to cover 100% of certain advisory and legal costs for the consortium streamlines the process and reduces financial burden on other consortium members.
• The proposed transaction aims to be structured as a tax-free, tax-deferred, or non-recognition event for the rollover equity, which could be beneficial for the rolling shareholders.

Negatives

• The proposal is non-binding, and there is no assurance that a definitive agreement will be reached or that the transaction will be consummated.
• The consortium reserves the right to modify or withdraw the proposal at any time.
• A limitation on warrant exercise prevents Fairfax from immediately increasing its beneficial ownership beyond 19.9% without shareholder approval, potentially complicating negotiations or future actions.
• The filing does not provide a premium analysis, so it is unclear how attractive the $10.25 offer is relative to recent market prices.

Risks

• The Proposed Transaction may not be consummated, as there are no assurances a definitive agreement will be reached.
• The Consortium reserves the right to modify or withdraw the Proposal at any time, with or without prior notice.
• The transaction is subject to various conditions, including potential shareholder approval for Fairfax to exceed 19.9% beneficial ownership from warrants.
• Regulatory approvals (antitrust, competition, foreign investment, etc.) are required, and while investors will cooperate, there is no obligation for any investor to divest material assets or accept significant restrictions.
• Failure to agree on a tax-efficient transaction structure for the rollover equity could lead to an investor withdrawing from the agreement.

Future Outlook

The consortium intends to engage in discussions and negotiations with Kennedy-Wilson's Board and a potential Special Committee regarding the Proposed Transaction. They plan to respond to inquiries, negotiate terms, and may engage advisors, seek financing, and prepare definitive agreements. No further updates are intended until a definitive agreement is reached or required by law.

Management Comments

• The members of the Consortium are only interested in acquiring the outstanding Shares of Kennedy-Wilson that they do not already own, and are not interested in selling their Shares to another party.
• The Consortium expects the Board will establish a special committee of independent directors fully empowered to select and retain its own independent legal and financial advisors.

Industry Context

This filing indicates a potential take-private transaction or a significant change in ownership structure for Kennedy-Wilson Holdings, Inc., a real estate investment company. Such moves often occur when large institutional investors or management believe the company is undervalued in the public market or can achieve greater strategic flexibility as a private entity. The involvement of Fairfax Financial, known for its long-term value investing approach, suggests a belief in the underlying value of Kennedy-Wilson's assets.

Comparison to Industry Standards

• The filing does not provide sufficient information to compare the proposed $10.25 per share offer to industry-specific valuation benchmarks or comparable transactions. A thorough assessment would require analyzing Kennedy-Wilson's financial performance (e.g., Price/FFO, Price/NAV) against its peers in the real estate investment sector and comparing the offer premium to historical take-private premiums for similar companies.
• The 19.9% beneficial ownership limitation due to warrants is a common anti-takeover or governance provision, often seen in investment agreements to prevent creeping control without broader shareholder consent.

Corporate Governance

Stakeholder Impact

• Shareholders: Non-consortium shareholders could receive $10.25 per share in cash if the transaction is completed, potentially realizing a premium.
• Management: William J. McMorrow, as a Management Principal, is part of the consortium and intends to roll over his shares, indicating continued involvement and alignment with the new structure. Other senior executive officers may also roll over their shares.
• Employees: No direct impact on employees is mentioned, but a take-private transaction could lead to operational changes in the long term.
• Creditors/Suppliers: No immediate direct impact mentioned.

Next Steps

• Kennedy-Wilson's Board is expected to establish a special committee of independent directors to evaluate the proposal.
• The consortium will engage in discussions and negotiations with the Board and the Special Committee.
• The consortium may modify or withdraw the proposal.
• The consortium may seek debt and/or equity financing for the transaction.
• The investors will negotiate and enter into governance agreements for the Bidco.
• If a Merger Agreement is executed, each investor will enter into a customary voting and support agreement with Bidco.

Key Dates

Recommendation

The filing details a non-binding proposal to acquire Kennedy-Wilson shares at $10.25 per share. While this represents a potential upside for current shareholders, the 'no assurances' clause and the right of the consortium to withdraw the offer introduce significant uncertainty. Investors should hold their shares to see if a definitive agreement is reached, as the offer price provides a floor for negotiation, but should not 'buy' based on a non-binding proposal. A 'sell' recommendation would be premature without further information on the likelihood of the deal closing or alternative offers.

Keywords

Kennedy-Wilson Holdings, Fairfax Financial Holdings, Kona Management Holdco, William J. McMorrow, Schedule 13D, Takeover Bid, Acquisition Proposal, Common Stock, Beneficial Ownership, Warrants, Real Estate Investment, Corporate Governance, Special Committee, Merger Agreement, Rollover Equity, SEC Filing